C3 and cancer: Their experiments display that C3 is released from cancer cells to interact with C3a receptor expressed on the surface of choroid plexus cells, inducing the disruption of the choroidal B-CSF barrier, allowing the entry of growth factors and cytokines in the CSF space, and conducting tumor growth in leptomeninges [32].